Jon Suh
Overview
Explore the profile of Jon Suh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
656
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Choi S, Jang J, Kim D, Suh Y, Baek Y, Shin S, et al.
Front Cardiovasc Med
. 2025 Feb;
11:1396243.
PMID: 39902089
Introduction: Hypoxic liver injury (HLI) and Killip classification are poor prognostic factors in patients with ST-segment elevation myocardial infarction (STEMI). This study investigates the interrelationship between hypoxic liver injury (HLI)...
2.
Choi K, Kim J, Kang D, Doh J, Kim J, Park Y, et al.
BMJ Open
. 2024 Dec;
14(8):e086971.
PMID: 39645270
Introduction: There is a lack of evidence to support the effectiveness of prolonged β-blocker therapy after stabilisation of patients with acute myocardial infarction (AMI) without heart failure (HF) or left...
3.
Kim Y, Yoon H, Suh J, Kang S, Lim Y, Jang D, et al.
JACC Cardiovasc Interv
. 2024 Nov;
18(2):187-197.
PMID: 39614852
Background: Recently developed artificial intelligence-based coronary angiography (AI-QCA, fully automated) provides real-time, objective, and reproducible quantitative analysis of coronary angiography without requiring additional time or labor. Objectives: This study aimed...
4.
Park H, Kang D, Ahn J, Yun S, Park K, Kang S, et al.
EuroIntervention
. 2024 Nov;
20(21):e1355-e1362.
PMID: 39492701
Despite the use of conventional dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI), the risk of adverse events remains high among patients with increased thrombotic risk. Until recently, the...
5.
Ahn J, Yu H, Park S, Suh J
Trials
. 2024 Oct;
25(1):727.
PMID: 39472953
Background: Various devices and techniques have been used for plaque modification in the treatment of severe coronary artery calcification. This prospective, multicenter, randomized, open-label study aims to evaluate the safety...
6.
Son J, Park J, Bang J, Kim D, Moon I, Kong M, et al.
Int J Mol Sci
. 2024 Sep;
25(18).
PMID: 39337705
Although coronary artery occlusion can have a negative effect on the myocardium, chronic total occlusion (CTO) exhibits different clinical features from those of acute myocardial infarction (AMI). In this study,...
7.
Kim Y, Park H, Yoon H, Suh J, Kang S, Lim Y, et al.
Am Heart J
. 2024 May;
275:86-95.
PMID: 38723880
Background: Artificial intelligence-based quantitative coronary angiography (AI-QCA) has been developed to provide a more objective and reproducible data about the severity of coronary artery stenosis and the dimensions of the...
8.
Moon I, Park S, Kim D, Park M, Park S, Kwon S, et al.
Int J Cardiol
. 2024 Apr;
407:132075.
PMID: 38643801
Background: Regarding the pathophysiology of renal infarction (RI), cardioembolic causes could have large proportion. However, there are notable variations in prevalence of atrial fibrillation (AF) among patients with RI across...
9.
Kong M, Moon I, Seo H, Suh J, Choi J, Na J, et al.
Int J Heart Fail
. 2024 Feb;
6(1):22-27.
PMID: 38303915
Body fluid monitoring and management are essential to control dyspnea and prevent re-hospitalization in patients with chronic heart failure (HF). There are several methods to estimate and monitor patient's volume...
10.
Kong M, Suh J, Lee B, Park H, Park S, Moon I, et al.
Cardiol J
. 2023 Nov;
31(3):434-441.
PMID: 37964646
Background: Not only hemo-dynamic (HD) factors but also hemo-metabolic (HM) risk factors reflecting multi-organ injuries are considered as important prognostic factors in ST-segment elevation myocardial infarction (STEMI). However, studies regarding...